Hyeong Joon Lim

Title: Hyeong Joon Lim: Innovator in Pharmaceutical Compounds

Introduction

Hyeong Joon Lim is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of peptide compounds. With a total of 3 patents to his name, Lim's work focuses on innovative solutions for health-related issues.

Latest Patents

One of Lim's latest patents is a peptide compound or a pharmaceutically acceptable salt thereof. This invention relates to a novel peptide compound that has potential applications in medicine. Another significant patent is a pharmaceutical composition for preventing or treating arteriosclerosis. This composition includes a pharmaceutically effective amount of a protein comprising the amino acid sequence of SEQ ID NO: 1, along with a pharmaceutically acceptable carrier. Notably, this composition exhibits no toxicity in the liver or kidney and effectively reduces the formation of atherosclerotic plaques, demonstrating its efficacy in treating arteriosclerosis.

Career Highlights

Throughout his career, Hyeong Joon Lim has worked with various companies, including Eyegene Inc. and Eyebio Korea. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

Lim has collaborated with several professionals in his field, including Jin Wook Jang and Yang Je Cho. These collaborations have likely enhanced his research and development efforts.

Conclusion

Hyeong Joon Lim is a distinguished inventor whose work in pharmaceutical compounds has the potential to make a significant impact on health care. His innovative patents reflect his commitment to advancing medical science and improving patient outcomes.